Cargando…
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
BACKGROUND: Lassa virus (LASV) is endemic in several West African countries and is the etiological agent of Lassa fever. Despite the high annual incidence and significant morbidity and mortality rates, currently there are no approved vaccines to prevent infection or disease in humans. Genetically, L...
Autores principales: | Safronetz, David, Mire, Chad, Rosenke, Kyle, Feldmann, Friederike, Haddock, Elaine, Geisbert, Thomas, Feldmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401668/ https://www.ncbi.nlm.nih.gov/pubmed/25884628 http://dx.doi.org/10.1371/journal.pntd.0003736 |
Ejemplares similares
-
Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015) -
Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018) -
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015) -
Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021) -
Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali
por: Safronetz, David, et al.
Publicado: (2013)